What methods ensure participant confidentiality in research, such as proper disposal of Protected Health Information (PHI) documentation, secure record storage, or assigning security codes to electronic records?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The correct answer is E. A, C, and D. Researchers must implement multiple safeguards to ensure participant confidentiality in clinical research. Properly disposing of documentation containing Protected Health Information (PHI) identifiers prevents unauthorized access after the information is no longer needed, as suggested by the need for safe disposal policies 1. Storing participant paper records in locked cabinets provides physical security against unauthorized access, which is in line with measures to ensure the physical security of confidential records 1. Assigning security codes to electronic records creates an additional layer of protection for digital information.

Option B is incorrect because maintaining a notebook of participant addresses and names in a researcher's personal papers would violate confidentiality principles by potentially exposing sensitive information. Good Clinical Practice (GCP) guidelines require comprehensive protection of participant information through multiple security measures working together, which is why the combination of proper disposal, secure physical storage, and electronic safeguards represents the correct approach to maintaining confidentiality. Furthermore, ensuring participant confidentiality is crucial for maintaining trust and facilitating open communication, especially in sensitive research areas where data sharing and participant consent are critical 1.

Key considerations for ensuring participant confidentiality include:

  • Proper disposal of documentation with PHI identifiers
  • Secure physical storage of participant records
  • Electronic safeguards such as assigning security codes to electronic records
  • Transparent communication with participants about data sharing and risks, as well as providing mechanisms for withdrawal from studies and data removal 1.

From the Research

Ensuring Participant Confidentiality

To ensure participant confidentiality, researchers use various practices, including:

  • Disposing properly of all documentation with Protected Health Information (PHI) identifiers
  • Storing participant paper records in a locked cabinet
  • Assigning security codes to electronic records

Correct Option

The correct option for ensuring participant confidentiality is:

  • E. A, C, and D

Justification

There are no research papers provided that directly assist in answering this question regarding the correct practices for ensuring participant confidentiality in the context of GCP certification. However, general principles of confidentiality and data protection suggest that disposing of documentation with PHI identifiers, storing records in a locked cabinet, and assigning security codes to electronic records are all appropriate measures 2, 3, 4, 5, 6 do not provide relevant information on this topic.

Related Questions

Do researchers and research institutions have the primary responsibility for reporting and investigating allegations of research misconduct, specifically regarding Good Clinical Practice (GCP)?
Must every aspect of a research study be documented in compliance with Good Clinical Practice (GCP) guidelines to obtain useful data?
What is the required timeframe for reporting a Serious Adverse Event (SAE) to the local Institutional Review Board (IRB) after becoming aware of the event?
What action should be taken in case of a protocol violation in a clinical trial?
Is it important that findings from a clinical study be generalizable to people with similar characteristics as the study participants, for Good Clinical Practice (GCP) certification?
What are the recommended laboratory tests for autoimmune disease diagnosis?
What is the treatment for globus sensation (globus pharyngeus)?
What are the causes of elevated erythrocyte (red blood cell) count?
What is the cause of paresthesia (tingling sensation) and numbness in a 31-year-old female with a history of recurrent pregnancy losses secondary to endometriosis, who is currently on birth control and was weaned off hormone therapy (hormone replacement therapy) due to In Vitro Fertilization (IVF)?
What is the treatment for acute lumbar radiculopathy (lumbago) with sciatica?
Do researchers and research institutions have the primary responsibility for reporting and investigating allegations of research misconduct, specifically regarding Good Clinical Practice (GCP)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.